Abstract
Atypical fibroxanthoma (AFX) is a spindle cell neoplasm with low metastatic potential but high tendency to recur after surgery. Because of the rarity of this lesion and its aspecific clinical features, AFX could be easily misdiagnosed and undertreated by many clinicians who encounter them. Dermoscopy represents a valuable tool for easily assessing skin lesions, even though histological examination is required for final diagnosis. We report a case of a cheek lesion with dermoscopic "blue amber pattern", easily recognisable and not observed in others skin tumours, which could represent an additional feature useful in differentiating this tumour from other skin neoplasms.
INTRODUCTION
Atypical fibroxanthoma (AFX) is an uncommon, locally aggressive malignant fibrohistiocytic tumour with a tendency for recurrence and a low metastatic potential [1] . Exposure to ultraviolet light represents a risk factor for its development. AFX is usually described as a solitary red or pink papule or extensively ulcerated nodule on the head or neck; nevertheless, early cases could be easily undiagnosed or misdiagnosed. Complete tumour excision could be critical in avoiding local recurrence [1] . Although the rarity of this neoplasm explains its low clinical suspicion, the absence of characteristic features contributes to the delay in diagnosis that it is usually reached through histopathological examination. Dermo scopy has proven to be a useful diagnostic tool in other cutaneous malignancies [2, 3] , but the unique published report concerning AFX shows that its dermoscopic features are noncontributory and nonspecific [4] . The correct preoperative diagnosis is therefore rarely made. Undertreatment usually will result in recurrence, since the recurrence rate for AFX is high even for cases treated appropriately and in a timely manner.
CASE REPORT
We present the case of a 69yearold female with a history of hypertension and occupational sun exposure. She was referred to our clinic for evaluation of an asymptomatic, rapidly growing violaceous nodule on her cheek that appeared 8 wk earlier ( Figure 1A ). The lesion was previously diagnosed twice as a basal cell carcinoma and accordingly treated with imiquimod and cryotherapy, but it recurred. Using dermoscopy, we observed on the right side of the lesion some irregular, linear vessels over a whitish veil. On the left side, however, we noticed a "blue amber" pattern consisting of bluish, homogeneous pigmentation surrounded by a purple halo with scattered yellowish inclusions ( Figure  1B and inset). The plaque was excised, and histological examination showed an intradermal tumour with no epidermal involvement, made up of a mixture of spindleshaped cells, histiocytelike cells, xanthomatous cells, and multinucleated giant cells with marked pleomorphism, hypercromasia, and prominent mitotic activity (Figure 2) . A diagnosis of AFX was made.
DISCUSSION
The correct diagnosis of AFX is difficult because of its rarity, so skin biopsy for obtaining histological examination is usually necessary. A handful of cases has been reported in the literature about dermoscopy of AFX. Bugatti et al [4] described these lesions as "slightly pigmented, reddish, malignant cutaneous tumours displaying prominent and chaotic dermatoscopic neoangiogenetic features in more advanced stages of proliferation". Lallas et al [5] described AFX as "typified by reddish and whitish areas in combination with polymor phous vascular pattern with various combinations of linear, dotted, hairpin and highly tortuous vessel irregularly distributed over the surface of the lesion". Pitarch et al [6] of the lesion. Therefore, as stated elsewhere, is highly recommended the excision of any skin lesion with the clinical features of elevation, firmness and growth [7] for avoiding AFX undertreatment. Although the vascular morphology of our lesion was suspicious for a malignant neoplasm, such as an adnexal tumour or amelanotic melanoma, the blue amber pattern, to our knowledge, had not been previously reported. The anatomical counterparts of this pattern are possibly represented by haemorrhagic areas in the periphery of the lesion, while xanthomatised cells could explain the yellow inclusions. The blue amber pattern is easily recognisable and is not observed in other skin tumours; it could represent an additional feature in the differential diagnosis between AFX and other skin neoplasms such as basal cell carcinoma, prompting a histological examination. We provide an easytorecognise dermoscopic pattern in a histologically proven case of AFX. Dermatologists should be aware of this pattern to avoid undertreating this neoplasm.
COMMENTS

Case characteristics
A 69-year-old female with a history of hypertension and occupational sun exposure with a nontender nodule on her cheek of eight weeks' duration.
Clinical diagnosis
Rapidly growing violaceous nodule on cheek.
Differential diagnosis
Basal cell carcinoma, merckel cell carcinoma.
Laboratory diagnosis
All labs were within normal limits.
Pathological diagnosis
Atypical fibroxanthoma (AFX).
Treatment
Complete surgical excision of lesion.
Related reports
AFX and solid neoplasm presenting as a solitary red or pink papule or extensively ulcerated nodule on the head or neck.
Term explanation
AFX: A locally aggressive malignant fibrohistiocytic tumour with a tendency for recurrence and a low metastatic potential.
Experiences and lessons
This entity is commonly undiagnosed or misdiagnosed. Dermoscopy have the potential for avoiding undertreatment of this tumour.
